Human Genome Epidemiology Literature Finder
|
Records 1 - 7 (of 7 Records) |
| Query Trace: Disease and CES1[original query] |
|---|
| The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Pharmacogenetics and genomics 2012 Oct . Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, Shuldiner AR |
| Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. European heart journal. Cardiovascular pharmacotherapy 2019 Sep . Lewis Joshua P, Backman Joshua D, Reny Jean-Luc, Bergmeijer Thomas O, Mitchell Braxton D, Ritchie Marylyn D, Déry Jean-Pierre, Pakyz Ruth E, Gong Li, Ryan Kathleen, Kim Eun-Young, Aradi Daniel, Fernandez-Cadenas Israel, Lee Ming Ta Michael, Whaley Ryan M, Montaner Joan, Gensini Gian Franco, Cleator John H, Chang Kiyuk, Holmvang Lene, Hochholzer Willibald, Roden Dan M, Winter Stefan, Altman Russ B, Alexopoulos Dimitrios, Kim Ho-Sook, Gawaz Meinrad, Bliden Kevin P, Valgimigli Marco, Marcucci Rossella, Campo Gianluca, Schaeffeler Elke, Dridi Nadia P, Wen Ming-Shien, Shin Jae Gook, Fontana Pierre, Giusti Betti, Geisler Tobias, Kubo Michiaki, Trenk Dietmar, Siller-Matula Jolanta M, Ten Berg Jurriën M, Gurbel Paul A, Schwab Matthias, Klein Teri E, Shuldiner Alan R, |
| Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease. Drug metabolism and personalized therapy 2020 Mar . Sychev Dmitriy, Skripka Alena, Ryzhikova Kristina, Bochkov Pavel, Shevchenko Roman, Krupenin Pavel, Ivashchenko Dmitriy, Kogay Veronika, Listratov Alexander, Krainyaya Arina, Gurinovich Olga, Sokolova Anastasiya, Napalkov Dmitriy, Fomin Vikt |
| Copy number variation in the CES1 gene and the risk of non-alcoholic fatty liver in a Chinese Han population. Scientific reports 2021 7 11 (1): 13984. Chen Bing Bing, Yan Jian Hui, Zheng Jing, Peng He Wei, Cai Xiao Ling, Pan Xin Ting, Li Hui Quan, Hong Qi Zhu, Peng Xian |
| Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes. Frontiers in pharmacology 2021 2 11 593982. Xu Ru-Jun, Kong Wei-Min, An Xiao-Fei, Zou Jian-Jun, Liu Li, Liu Xiao-Do |
| Randomized evaluation of the loss-of-function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamics. Clinical and translational science 2024 11 17 (11): e70079. Joshua P Lewis, Kathleen A Ryan, Elizabeth A Streeten, Hilary B Whitlatch, Melanie Daue, Keith Tanner, James A Perry, Jeffrey R O'Connell, Alan R Shuldiner, Braxton D Mitche |
| CYP2C19 and CES1 gene variants affecting clopidogrel metabolism in a South Asian population from Sri Lanka. Pharmacogenomics 2025 1 1-4. Priyanga Ranasinghe, Pulasthi B Gunarathna, Hajanthy Jeyapragasam, Nirmala Sirisena, D P Bhagya Hendalage, Vajira H W Dissanaya |
- Page last reviewed:Feb 1, 2024
- Content source: